Europe’s Nuclear Deterrent: How to Erode the Foundation of Russia’s Nuclear Threats Capitalizing on Small European Powers’ Advantages
CONTEMPORARY MILITARY CHALLENGES · 01.12.2025 · 27 (4) · 71-79
DOI: 10.2478/cmc-2025-0032 ↗Kurz gefasst
Fachartikel in der Zeitschrift CONTEMPORARY MILITARY CHALLENGES, online erschienen am 10.03.2026. Verfasst von Eleni Ekmektsioglou. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The article analyses the renewed relevance of nuclear deterrence in Europe following Russia’s invasion of Ukraine and presents arguments that nuclear policy is not exclusively the domain of the major powers. The author argues that Europe does not need to emulate American strategies or larger arsenals, but rather an adapted approach focused on a reliable second-strike capability, command and control resilience, and strong conventional deterrence. She attributes a special role to small and medium-sized European countries, which can use diplomacy, political pressure, and the stigmatization of nuclear threats to raise the political cost of nuclear use and thus weaken the credibility of Russian nuclear blackmail.
Zitieren
APA
Ekmektsioglou, E. (2025). Europe’s Nuclear Deterrent: How to Erode the Foundation of Russia’s Nuclear Threats Capitalizing on Small European Powers’ Advantages. CONTEMPORARY MILITARY CHALLENGES, 27(4), 71-79. https://doi.org/10.2478/cmc-2025-0032
Vancouver
Ekmektsioglou E. Europe’s Nuclear Deterrent: How to Erode the Foundation of Russia’s Nuclear Threats Capitalizing on Small European Powers’ Advantages. CONTEMPORARY MILITARY CHALLENGES. 2025;27(4):71-79. doi:10.2478/cmc-2025-0032
BibTeX
@article{Ekmektsioglou2025,
author = {Ekmektsioglou, Eleni},
title = {Europe’s Nuclear Deterrent: How to Erode the Foundation of Russia’s Nuclear Threats Capitalizing on Small European Powers’ Advantages},
journal = {CONTEMPORARY MILITARY CHALLENGES},
year = {2025},
volume = {27},
number = {4},
pages = {71--79},
doi = {10.2478/cmc-2025-0032}
}
EUVIMED